Skip to main content
MREO logo

MREO · Mereo BioPharma Group plc

$0.31 +0.01 (+2.58%)
Market Cap
$241.10M
Shares
798.09M

Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.

Equity Offering (ATM) Programs

Program Established Capacity Remaining Runs Through
2023-07-01
Key facts CIK 1719714 CUSIP 589492107 13F (30d) 5 filings 5 filers Visit website Investor relations